chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mother, reported reaction on behalf of patient. Reported stomach hurting and nausea starting one day after the vaccination. Stomach pain continued off and on for about 1 week. Mother noted that patient did not ever vomit. Patient had a decrease in appetite, tired/fatigue, feeling out of sorts, irritability, and over emotional for that week also. Mother states that 2 days after the vaccines, that patient reported a headache and was given advil just one time, the symptom resolved and no further medication was given. Mother reports no local reaction at the site of either vaccine. Mother reports that 8 days after the vaccine patient stated that all symptoms resolved (5/29). On 5/30, patient's appetite returned to normal and he was acting like his normal self. That is when she contacted our office to let us know what had happened.
I had a migraine everyday after first dose through the second dose. I received medical attention to reverse the symptoms. I have also had severe lower back pain but not sure if it is related.
Suspected vaccination failure; got the worst case of shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the dose of Shingles vaccine and got the worst case of shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Patient contracted COVID after being fully vaccinated.  No booster. Congestion, Cough, Runny Nose
I ended up getting COVID and pre hypertension. I was diagnosed with COVID on 10/13/2021. The symptoms, headache, fatigue, nauseau, difficulty breathing. I was breastfeeding at the time and my baby had all the same symptoms. We were both diagnosed with COVID. The symptoms started a week after I got the vaccine. I wasn't given any medications, just to rest and stay home.
2/11/10 Onset left lateral abdomen fat, pale pink skin rash/lesion day after Tdap booster 2/10/10, seen 2/17/10 for Benign positional vertigo (7 days after Tdap).  Follow- up information - Patient's last name updated.
pt recv vax 20MAY96 & 29MAY96 pt exp swollen lymph nodes & glands in neck & axilla area, sore throat & bad cough;30MAY96 pt devel a fever to 102 which reached 103 by 31MAY96;1JUN96 pt exp stiff neck & devel a fine maculopapular rash;
Pt reports approximately 2 hrs post vaccine she developed an injection site reaction characterized by redness and swelling, she then developed a fever and muscle aches.
WARM, REDNESS AND SWELLING AT THE SITE, TENDER TO TOUCH.
Pt had a hard time sleeping that night; in am noticed bruising on arm and veins up neck/collar bone; went to ER and was dx with vasculitis; was told to ice arm and take ibuprofen.
LIGHTHEADED, PALPITATIONS; BP 179/92, HR 99 O2 SAT 99% REPEAT 155/90; HR 88 O2 SAT 99-100%
Initial report received 29 October 2009 from a health care professional. This report consisted of a cluster of two patients. The other patient has been captured in case number 2009-04638. A 64-year-old female patient who is also a physician, had received an intramuscular gluteal injection if (H1N1) 2009 Monovalent Vaccine - Preservative, lot number UP005AA on 27 October 2009 and later that evening, she developed flu-like symptoms which included a headache and body aches. The patient also developed cellulitis and swelling of the buttock and complained of pain in her neck and legs. The reporter noted that the (H1N1) 2009 Monovalent Vaccine - Preservative had been pre-drawn days earlier at another facility and was sent to the facility where she had been vaccinated. A one inch needle length had been used for vaccine administration. Corrective treatments were not reported. At the time of the report, the symptoms continued and the patient had not recovered. The reporter for this case is the same as for case number 2009-04638.
pt is immunocompromised and came in for 2nd booster (4th dose). we gave her full dose of 0.5ml instead of 0.25ml recommended for second booster 4th dose
Information has been received from the healthcare worker who reported that on 06-MAY-2014, a 12 month old patient of unspecified gender was vaccinated with a single dose (was exposed to 47 F for 4 hours) reported as 0,5 (units not provided) of MMR II (lot# J003790, expiration date: 28-MAR-2015) (dose number and route were not provided). This is one of several reports received from the same reporter. Additional information has been requested.
in my left under arm area, in my arm, its sore there; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 (Lot number: EM6208) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN; AMLODIPINE. The following information was reported: AXILLARY PAIN (non-serious) with onset 04Apr2021, outcome "not recovered", described as "in my left under arm area, in my arm, its sore there". Therapeutic measures were not taken as a result of axillary pain.  Additional information: Patient had the first vaccine on March 24 ( further clarification unknown), and today Patient woke up and in left under arm area, in arm, its sore there. It's been 10 days.  No follow-up attempts are possible. No further information is expected.
During the injection there was a drop of vaccine that came out and ran down the patient's arm.  It leaked out where the leur slip is.  Since there is no leur lock on these syringes there is no way to tighten it down prior to injection.  We are just pushing down to secure it best as possible.  The patient was very upset and demanded another dose right then.  I advised that I am not authorized to give her another injection at that time.  I advised that it would be reported and then followed up.  She was going to cancel all of her upcoming appointments.  I advised not to do that and that even if she had received the entire dose that it would still be recommended to follow the CDC's guidelines and continue to wear a mask, practice social distancing and to maintain proper hand hygiene as well as wash her hands several times daily.  Patient is calm awaiting direction from our office.
5 yo with swelling at site of injection. No induration. There is slight erythema.
Pain at injection site and upper left arm,  headache,  muscle/body aches,  fatigue/tiredness.  Pain still there, headache gone after 12 hours, muscle/body aches still there but less, fatigue/tiredness still there.
1. Patient was administered Pfizer monovalent covid vaccine after the authorization for use had expired April 18, 2023. 2. Patient was prescribed Pfizer Bivalent vaccine and was given Pfizer monovalent vaccine in error.
This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and feeling miserable. On an unknown date, the outcome of the vaccination failure, shingles and feeling miserable were unknown. It was unknown if the reporter considered the vaccination failure, shingles and feeling miserable to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The patient had both shingles shots and still came back with shingles and patient felt so miserable. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.
Information has been received from a Registered Pharmacist concerning a "over age of 65" female who on approximately 27-MAR-2009, " about 1 week ago" was vaccinated with ZOSTAVAX (Merck) (lot # not reported), 0.65 ml via subcutaneous. On approximately 28-MAR-2009, the day after receiving ZOSTAVAX (Merck), the patient experienced itching, swelling and bruising. The patient's itching and swelling and bruising persisted. On an unspecified date, the patient sought medical attention, via pharmacist. Additional information has been requested.
Received vaccine at 0900.  At 2100, chills, body aches.  At 2300, itching left elbow that progressed.  Seen at 0600 next day and diagnosed with hives.  No anaphylaxis.  However, as precaution he was given epi, solumedrol iv, and Benadryl po.  Patient discharged to room.  He is in setting overseas.
Patient noted to have new onset pain and weakness of the LLE with associated erythematous papular rash on the dorsal aspect of the foot.
Loss of sense of taste and smell; Loss of sense of taste and smell; High pressure feeling in his nose; Injection site pain; Muscle soreness; This is a spontaneous report from a non-contactable Other HCP. A 23 year old male patient received BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine) lot number not reported, via an unspecified route of administration on 11Jan20201 11:00 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 11Jan2021 the patient experienced, within half hour from vaccine administration, injection site pain and muscle soreness both with outcome of unknown. On 13Jan2021 he experienced loss of sense of taste and smell, mixed with high pressure feeling in his nose with outcome of unknown. The patient reported that "with loss of taste and smell, what is my next step, do I stay home, do I go back to work, what do I do. My work wants to know if I can come back or not. I also know someone that I work with that had a metallic taste in his mouth". The action taken was not applicable.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Following a 1st dose of Engerix-B (given 18JUL90) vaccinee had a red, swollen arm; Next day 19JUL90 was "not feeling well" & was sent home from work; 20JUL90 had a temp of 101 unk if any tx was given; "all better" by 21JUL90;
This spontaneous case reported by a consumer, describes the occurrence of inappropriate schedule of product administration (received Moderna vaccine while positive with COVID-19) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 007B21A) for COVID-19 immunization. No medical history reported. On Mar 30, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 30, 2021, patient experienced inappropriate schedule of product administration (received Moderna vaccine while positive with COVID-19). On Mar 30, 2021, inappropriate schedule of product administration (received Moderna vaccine while positive with COVID-19) resolved. Diagnostic results: On Mar 27, 2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Severe a headache that does not go away even with 3 Advil's   . Headache started 1 week post vaccination and is constant.
This spontaneous report was received from a registered nurse referring to "about 25" patients of unknown age and gender. The patient's medical history or concurrent condition were not provided. On unknown dates the patients were vaccinated with improperly stored doses of ROTATEQ (lot#, dose, dose number were unspecified) orally. No adverse effects were reported. Additional information has been requested.
Lightheadedness; Sweating on palm of hands; Face felt numb; This case was reported by a other health professional via call center representative and described the occurrence of light headedness in a 47-year-old male patient who received HAB (Twinrix adult) (batch number 9355D, expiry date 14th March 2022) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Twinrix adult. On 27th August 2019, 1 hr after receiving Twinrix adult, the patient experienced light headedness, sweating increased palms and numbness facial. On an unknown date, the outcome of the light headedness, sweating increased palms and numbness facial were recovered/resolved.   It was unknown if the reporter considered the light headedness, sweating increased palms and numbness facial to be related to Twinrix adult.  Additional case details were reported as follows: The patient experienced lightheadedness, sweating on palm of hands, and face felt numb.  The events began about 1 hour after injection. The events were resolved. The reporter consented to follow up. This is 3 of the 3 linked cases reported by the same reporter.
Patient noticed swelling around vaccination adminsitration site and began to experience stomach pain. She then notified a staff nurse who took her to the acute care area and notified the duty doctor. She then began feeling a minor difficulty in breathing, and was treated for anaphylaxis.
Mother called about child. Said his left arm, Deltoid, was red and swollen. I explained child probably tighten up his arm, muscle when shot was given plus that arm got Dtap along with Hep A. She also said his right arm hurt, Deltoid where he got his flu shot along with a Proquad-SQ. She also said where the flu shot was given, it was a little itchy. Told mother to put cool compress on it give with Tylenol or Motrin prn. If the arm is still itchy, give Benadryl prn. Any other problems call PCP
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 57 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 20Jan2021 as dose 1, single (Batch/Lot number: unknown), on 10Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 03Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 21May2022 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing), notes: known allergies: Penicillin. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient returned of Covid symptoms. Last dose of Paxlovid taken on 21Sep2022. Tested negative on 23Sep2022. Symptoms returned (stuffy/itchy nose, congestion) evening of 25Sep2022. Tested positive twice. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (23Sep2022) Negative; (25Sep2022) Positive, notes: Tested positive twice; (25Sep2022) Positive, notes: Tested positive twice. Therapeutic measures were taken as a result of vaccination failure, covid-19: Paxlovid from 16Sep2022 to 21Sep2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Three days after her second HPV she noticed pain in knees, thighs and hips. Pain stopped over Spring break. Started again in May.
Patient developed a rash covering the front and back of her body from head to hips.  The rash was itchy and patient stated that she used Benadryl and hydrocortisone cream with the Benadryl not helping and the cream helping minimally.  She was seen at her primary care doctor's office who suggested that she not get the second shot.  Patient was given Prednisone 20mg tablets to take 2 tablets once daily for 5 days on 10/9/20 because she is still having symptoms.
(name) experienced intermittent chest pain (severe at times) starting from 2nd day of vaccination which lasted for about 4 days. At that point I was unaware of any such side effect of the pfizer vacci; This is a spontaneous report from a contactable consumer or other non hcp.   A 13-years-old male patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: ER8727), dose 2 via an unspecified route of administration, administered in Arm Left on 06Jun2021 dose 2, single for covid-19 immunisation. The patient medical history and concomitant were not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID.It was Reported that, patient experienced intermittent chest pain starting from 2nd day of vaccination which lasted for about 4 days. At that point I was unaware of any such side effect of the Pfizer vaccine, so I did not report it immediately on 07Jun2021 with outcome of recovered.  Follow-up attempts have been completed and no further information is expected
Pt recvd vax on 3OCT89 & w/in 30 to 35 minutes following the vax pt went limp & had glazed eyes; on the morning of 6OCT89 pt was awake, standing in crib & was crying; w/in 1/2 hr, pt became lethargic, listless & unresponsive to name;
24 hours after 5th dose of anthrax, patient developed large local reaction from upper arm to wrist, AND tinnitus.  Sx's lasted about 5 days before resolving sponteneously.  No meds taken.  Went to ER when sx's started, but no treatment given in ER.  Had 4 prior doses of anthrax --> had local reactions, which became bigger with each subsequent shots, but never larger than palm of hand.  4th anthrax shot was in 2000 (2-3 years before the 5th dose).
This spontaneous report as received from a pharmacist refers to two unspecified patients of unknown age and unknown gender. No medical history and concurrent conditions were reported. On 25-SEP-2015, the patients were vaccinated with properly stored MMR II (lot number and expiry date were not reported0 which was reconstituted with improperly stored sterile diluent (lot# K026419 and expiry date: 19-OCT-2017, lot# L012345 and expiry date: 23-JAN-2018), each receiving one dose each on 25-SEP-2015. No adverse effects were reported. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of chills, myalgia (muscle aches), injection site rash (patch on the injection site), injection site erythema (big red patch on the injection site) and injection site warmth (warm itchy patch on the injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 029A21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 6, 2021, patient experienced chills, myalgia (muscle aches) and pain. On Mar 17, 2021, patient experienced injection site rash (patch on the injection site),  injection site erythema (big red patch on the injection site), injection site warmth (warm itchy patch on the injection site) and injection site pruritus (itchy patch on the injection site). At the time of the report, chills, myalgia (muscle aches), injection site rash (patch on the injection site), injection site erythema (big red patch on the injection site), injection site warmth (warm itchy patch on the injection site), injection site pruritus (itchy patch on the injection site) and pain outcome: unknown/not provided The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular:  unknown. No concomitant product and treatment information reported.
Anaphylactic reaction; A spontaneous report was received from a 23-year-old, female consumer who was also a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced anaphylactic reaction.   The patient's medical history included allergy to amoxicillin. Concomitant medications reported included gabapentin, escitalopram oxalate, and montelukast sodium.  On 04 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 05 Jan 2021, within 24 hours of vaccination, the patient experienced anaphylactic reaction. Treatment for the event included Diphenhydramine.  Action taken with mRNA-1273 in response to the event was not provided.  The outcome of the event, anaphylactic reaction, was considered resolved on 06 Jan 2021.; Reporter's Comments: This case concerns a 23 year old female patient, who experienced a serious unexpected event of Anaphylactic reaction. Event occurred apparently within 24 hrs. after first dose of mRNA-1273 (Lot# 011L20A) vaccine administration. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild.
Patient experienced febrile seizure after receiving VAXELIS, ROTATEQ, and PREVNAR 13; This spontaneous safety report, with reference number 02411495 (Interaction # 02411489) was received by the partner on 20-JUN-2023 and forwarded to agency on 21-JUN-2023, from a health professional.   The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Patient experienced febrile seizure after receiving VAXELIS, ROTATEQ, and PREVNAR 13".   Further information is expected.
Lip swelling, within 20 minutes, given benedryl  50 mg, followed by a red rash on both arms , legs and trunk one week after injection.
Three days after receiving the Pfizer COVID 19 vaccination patient report waking up with chills, and heart racing .  She did not take her temperature or pulse at the time. The chills and heart racing lasted about 15 minutes total while the patient was lying in bed.  She has never had these symptoms before.  She had no other associated symptoms at the time including, nausea, vomiting, sweating, dizziness, shortness of breath, chest pain, abdominal pain.   Once the episode passed she got up and performed her usual routine.  She noted her blood pressure was a little higher than normal at 140-145 systolic.  Pulse was normal at that time on her machine.  She continued to feel "wobbly in her legs" throughout the rest of the day and was back to her usual state of health by the next morning.
Patient was inadvertently given the vaccine approved for ages 12+. PCP notified patient of event 12/14/2021. MOC denied any adverse side effects.
Few bumps at left arm site 1-2 days after shot. Then petechiae along left shoulder to wrist over following 7 days.
As ordered by FNP x1 Tdap (IM) vaccine was given to 16 0/7 wks gestational age female pt. Vaccine was given outside of CDC recommendations for gestational age.